February 25, 2024

The Global West Nile Virus Market Growth Accelerated By Increased Demand For Early Diagnosis And Therapeutics

West Nile Virus diagnostic kits are witnessing higher adoption owing to the need for early detection of the viral infection. Easy availability and accurate test results within few hours allow physicians to promptly begin the appropriate course of treatment. Further, the rising awareness regarding WNV infection symptoms and preventive measures amongst general population has fueled the demand for diagnostic testing. The growing therapeutic developments to curb the virus and manage West Nile fever are also boosting the market growth.

The global West Nile Virus Market is estimated to be valued at US$ 634.8 Mn in 2023 and is expected to exhibit a CAGR of 3.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Major players are focusing on developing novel diagnostic platforms utilizing techniques such as real time polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), and immunohistochemistry. These techniques allow detection of West Nile virus within few hours as compared to conventional methods. For instance, in 2021, Luminex Corporation announced the launch of xTAG GPP West Nile Virus Assay which uses the xTAG technology for rapid detection of West Nile virus. Such improvements in diagnostic tests are expected to boost early diagnosis and management of West Nile virus infection.

Segment Analysis

The global West Nile Virus market is segmented based on type of treatment into symptomatic treatment and preventive treatment. The preventive treatment segment accounted for the highest market share in 2024 as preventive measures such as vaccination against West Nile virus is the most effective way to curb the spread of the infection.

Key Takeaways

The Global West Nile Virus Market Size is expected to witness high growth over the forecast period. The global West Nile Virus Market is estimated to be valued at US$ 634.8 Mn in 2023 and is expected to exhibit a CAGR of 3.8% over the forecast period 2023 to 2030.

Regional analysis North America dominated the global market in 2024 and is expected to continue its dominance over the forecast period. Factors such as rising awareness about treatments and preventive measures are driving the market in the region.

Key players operating in the West Nile Virus market are Aptar Group, Inc., RPC Group Plc, Gerresheimer AG, Amcor Limited, Albea S.A., Libo Cosmetics Company, Ltd, Quadpack Industries, HCP Packaging, Fusion Packaging, and ABC Packaging Ltd.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it